Abstract
Botulinum toxin is one of the most potent and deadliest substances on earth. Because of its unique mechanism of action at the synaptic junction and the ability to precisely deliver the toxin locally to where it is needed, botulinum toxin has been used as an effective treatment for a plethora of diseases from head to foot, from chronic migraine to ankle spasticity. Unlike systemic drugs, botulinum toxin is delivered by injection to the site of disease. As we will see from the history of botulinum toxin, the ability to deliver the drug locally to minimize the amount of botulinum toxin needed and thereby minimizing systemic exposure has been key to its medical utility. Botulinum toxin was first approved by the US Food and Drug Administration in 1989 for the treatment of blepharospasm and strabismus, but the history starts long before this, with outbreaks of food poisoning in the tenth century. Importantly, the development of botulinum toxins for medical use continues today with the engineering of novel toxins to treat disease.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Burke GS (1919) The occurrence of Bacillus botulinus in nature. J Bacteriol 4:541–553
Carruthers JD, Carruthers JA (1992) Treatment of glabellar frown lines with C. botulinum-A exotoxin. J Dermatol Surg Oncol 18:17–21
Clark RP, Berris CE (1989) Botulinum toxin: a treatment for facial asymmetry caused by facial nerve paralysis. Plast Reconstr Surg 84:253–255
Devriese P (1999) On the discovery of Clostridium botulinum. J Hist Neurosci 8:43–50
Drachman DB (1964) Atrophy of skeletal muscle in chick embryos treated with botulinum toxin. Science 145:719–721
Edmunds CW, Keiper GF (1924) Further studies on the action of botulinus toxin. JAMA 83:495–502
Elston JS, Lee JP, Powell CM et al (1985) Treatment of strabismus in adults with botulinum toxin A. Br J Ophthalmol 69:718–724
Erbguth FJ, Naumann M (1999) Historical aspects of botulinum toxin: Justinus Kerner (1786-1862) and the “sausage poison”. Neurology 53:1850–1853
Homann M, Sansjofre P, Van Zuilen M et al (2018) Microbial life and biogeochemical cycling on land 3,220 million years ago. Nat Geosci 11:665–671
Keen M, Blitzer A, Aviv J et al (1994) Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study. Plast Reconstr Surg 94:94–99
Lacy DB, Tepp W, Cohen AC et al (1998) Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol 10:898–902
Monheit GD, Pickett A (2017) AbobotulinumtoxinA: a 25-year history. Aesthet Surg J 37:S4–S11
Rizo J, Sudhof TC (1998) Mechanics of membrane fusion. Nat Struct Biol 5:839–842
Schantz EJ, Johnson EA (1992) Properties and use of botulinum toxin and other microbial neurotoxins in medicine. Microbiol Rev 56:80–89
Schantz EJ, Stefanye D, Spero L (1960) Observations on the fluorescence and toxicity of botulinum toxin. J Biol Chem 235:3489–3491
Scott AB (1980a) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology 87:1044–1049
Scott AB (1980b) Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. J Pediatr Ophthalmol Strabismus 17:21–25
Snipe P, Sommer H (1928) Studies on botulinus toxin. 3. Acid precipitation of botulinus toxin. J Infect Dis 43:152–160
van Ermengem E (1979) Classics in infectious diseases. A new anaerobic bacillus and its relation to botulism. E. van Ermengem. Originally published as “Ueber einen neuen anaëroben Bacillus und seine Beziehungen zum Botulismus” in Zeitschrift für Hygiene und Infektionskrankheiten 26: 1-56, 1897. Rev Infect Dis 1:701–719
Whitman WB, Coleman DC, Wiebe WJ (1998) Prokaryotes: the unseen majority U S A. Proc Natl Acad Sci 95:6578–6583
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Whitcup, S.M. (2019). The History of Botulinum Toxins in Medicine: A Thousand Year Journey. In: Whitcup, S.M., Hallett, M. (eds) Botulinum Toxin Therapy. Handbook of Experimental Pharmacology, vol 263. Springer, Cham. https://doi.org/10.1007/164_2019_271
Download citation
DOI: https://doi.org/10.1007/164_2019_271
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-66305-6
Online ISBN: 978-3-030-66306-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)